• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PFE

PFE

Pfizer Inc.

NYSEHealthcareDrug Manufacturers - GeneralUS

USD25.36

-0.20 (-0.76%)

Rating:B+

Company Profile

CEO

Albert Bourla

IPO Date

1972-06-01

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NYSE

Country

US

Market Metrics

Open

$25.43

Prev. Close

$25.55

Day Low

$25.29

Day High

$25.62

52W Low

$23.08

52W High

$28.75

Market Cap

$144.51B

Volume

21.74M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

57.9%

Avg Negative

2.0%

Avg Neutral

40.0%

News Feed

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

cnbc.com·5/28/2026·↑ positive

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

reuters.com·5/28/2026·↑ positive

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

prnewswire.com
·5/28/2026
·↑ positive

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

businesswire.com·5/28/2026·↑ positive

Insiders Aren't Buying Pfizer Stock at $26 and That's Actually a Good Thing

247wallst.com·5/28/2026·↑ positive

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

gurufocus.com·5/27/2026·↑ positive

Pfizer Bets on New & Acquired Drugs to Offset Its LOE Pressure?

zacks.com·5/27/2026·↑ positive

Astellas Targets ¥4.3 Trillion Profit Push As Xtandi Pressure Builds

gurufocus.com·5/26/2026·↑ positive

If Viking Therapeutics Is Acquired, Here’s Who Wins

247wallst.com·5/26/2026·↑ positive

This Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe?

fool.com·5/25/2026·↑ positive